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Background: High-energy photon and electron therapeutic beams generated in medical lin-
ear accelerators can cause the electronuclear and photonuclear reactions in which neutrons
with  a broad energy spectrum are produced. A low-energy component of this neutron radi-
ation induces simple capture reactions from which various radioisotopes originate and in
which the radioactivity of a linac head and various objects in the treatment room appear.
Aim: The aim of this paper is to present the results of the thermal/resonance neutron ﬂu-
ence measurements during therapeutic beam emission and exemplary spectra of gamma
radiation emitted by medical linac components activated in neutron reactions for four X-
ray  beams and for four electron beams generated by various manufacturers’ accelerators
installed in typical concrete bunkers in Polish oncological centers.
Materials and methods: The measurements of neutron ﬂuence were performed with the use
of  the induced activity method, whereas the spectra of gamma radiation from decays of
the  resulting radioisotopes were measured by means of a portable high-purity germanium
detector set for ﬁeld spectroscopy.
Results: The ﬂuence of thermal neutrons as well as resonance neutrons connected with
the  emission of a 20 MV X-ray beam is ∼106 neutrons/cm2 per 1 Gy of a dose in water at a
reference depth. It is about one order of magnitude greater than that for the 15 MV  X-ray
beams and about two orders of magnitude greater than for the 18–22 MeV electron beams
regardless of the type of an accelerator.
Conclusion: The thermal as well as resonance neutron ﬂuence depends strongly on the type
and  the nominal potential of a therapeutic beam. It is greater for X-ray beams than for elec-
trons. The accelerator accessories and other large objects should not be stored in a treatment
room during high-energy therapeutic beam emission to avoid their activation caused by
thermal and resonance neutrons. Half-lives of the radioisotopes originating from the simplecapture reaction (n,) (from minutes to hours) are long enough to accumulate radioactivity of
components of the acceler
the  additional doses to sta
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Fig. 1 – The view of the detection system with a high-purity
germanium detector by ORTEC (1 – the aluminum shield of
the germanium crystal, 2 – container with liquid nitrogen, 3
– electronic modules – multichannel analyzer, ampliﬁer,340  reports of practical oncology an
1.  Background
High-energy photons and electrons used in radiotherapy can
cause nuclear reactions (i.e. electronuclear and photonuclear
reactions1–4) in which neutron radiation is produced. This
problem was investigated by many  authors.5–19 The resulting
neutrons have a broad energy spectrum with mean energy
of several hundred keV.5–9 Signiﬁcant contribution to the
spectrum is given by thermal and resonance neutrons.10–12
These low-energy neutrons come into being as a result of a
slow-down processes (elastic scattering, mainly) of neutrons
produced in the above mentioned reactions. The neutrons are
slowed down mainly in walls, ﬂoor and ceiling of a treatment
facility. The thermal and resonance neutrons can cause simple
capture reactions from which various radioisotopes originate
and in which the radioactivity of air, linac head and vari-
ous objects in the treatment room appear. The main sources
of neutrons are large components of linac head13 i.e. colli-
mators of the beam, a ﬂattening ﬁlter, a target in the case
of X-ray beams and, additionally, scattered foils instead of a
ﬂattening ﬁlter in the case of electron beams. The resulting
neutrons can travel through a treatment room and a maze.8
Thus, simple capture reactions can take place in the whole
treatment facility. A comprehensive knowledge of the nuclear
reactions and radioisotopes induced during emission of ther-
apeutic beams generated by medical linacs was presented in
many papers.14–21
2.  Aim
The main aim of this paper is to present the results of mea-
surements of the thermal and resonance neutron ﬂuence in
the vicinity of a medical linac during emission of various high-
energy therapeutic beams. Additionally, exemplary spectra of
gamma radiation emitted by medical linac components acti-
vated in neutron reactions are shown. The purpose of this
part of the study was to identify gamma  emitters induced in
neutron reactions in linac accessory during emission of high-
energy photon/electron therapeutic beams. The presented
investigations were carried out for four various therapeutic
electron beams and for four X-ray beams generated by three
various manufacturers’ medical linacs installed in typical con-
crete bunkers in three Polish oncological centers: the Center
of Oncology in Gliwice, the Stanisław Leszczyn´ski Memorial
Hospital in Katowice and the Greater Poland Cancer Centre in
Poznan´.
3. Materials  and  methods
3.1.  Measurements  of  the  thermal  and  resonance
neutron  ﬂuence
The measurements of the thermal and resonance neutron
ﬂuence were performed with the use of the induced activ-
ity method. This method uses the dependence between the
indium foil activity caused by thermal/resonance neutrons
and the thermal/resonance neutron ﬂuence. The neutron acti-
vation detectors were indium foils (115In isotope) in the shapeetc., 4 – laptop).
of a circle with the radius of 0.75 cm.  The foil superﬁcial den-
sity was in the range from 98 to 110 mg/cm2. Isotope 115In
is characterized by a relatively high cross section of 160 b22
for a simple thermal neutron capture reaction. It also has a
high resonance of about 28,000 b23 at 1.45 eV and a number
of lower resonances in the 3.5 eV to 1 keV range for the above-
mentioned reaction, yielding the resonance activation integral
of 2700 b.24
The measurement of the thermal/resonance ﬂuence
consisted of two stages. In the ﬁrst stage, the indium foil was
placed at a chosen location in the neutron ﬁeld induced by a
therapeutic beam inside a treatment room. The indium foil
was activated by a capture of neutrons. The thermal and reso-
nance neutrons activate the indium according to the following
reaction:
115
49 In + 10n → 116m49 In (unstable, half-life T1/2 = 54.21 m)
followed by radioactive decay. The unstable state 116mIn disin-
tegrates by ˇ− decay into the exited state 116Sn*. Deexcitation
of this state gives gammas. In the second stage, the activated
foil was removed to the operator room after the therapeutic
beam emission and it was located on the surface of the germa-
nium detector shield to measure the indium foil activity. In the
presented investigation, the detection system with the high-
purity germanium detector by ORTEC (Fig. 1) was applied to
measure the activity of the foil on the basis of a measurement
of a spectrum of gammas  emitted by the activated indium. In
the presented investigation, the foil activity was determined
by a net count area NCA of the peak at 1293.54 keV (Fig. 3), using
the calibration factor K. The factor K was deﬁned as a ratio of
the activity of the calibration source 60Co to net count area of
the peak at 1332.50 keV in the gamma  energy spectrum emit-
ted by the 60Co source used for the calibration. The energy
of 1332.50 keV is close to 1293.54 keV from gammas  emitted
by the activated indium foil. The calibration source was in the
same shape and it had the same surface as the applied indium
foils.
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Fig. 2 – Scheme of the accelerator bunker with the denoted
locations of the measurements of the thermal/resonancereports of practical oncology and 
The cadmium cover method was applied to separate the
hermal neutron ﬂuence and the resonance neutron ﬂuence.
ach measurement of the neutron ﬂuence was performed
wice: ﬁrst by the use of the indium foil placed in a 1 mm thick
admium shield, and then after the decay of the excited nuclei
ut without the shield. The cadmium shield absorbs almost
ll thermal neutrons but it lets through most of resonance
nes. Thus, the total activity of the indium foil covered by
admium is induced by resonance neutrons. However, a part
f the resonance neutrons is absorbed in the cadmium layer.
 correction for this absorption needs to be applied. For this
urpose, the correction factor FCd was applied. FCd depends
n a kind and a superﬁcial density of a foil material used as
ell as a thickness of the cadmium layer.25 It was 1.13 for
he applied indium foil and the cadmium shield. The indium
oil activity Ares caused by resonance neutrons is a product
f the activity of the foil that was in the cadmium shield
uring the measurement and the correction factor FCd. Thus,
res = NCAin Cd × K × FCd, where NCAin Cd is a net count area of
he peak at 1293.54 keV in the spectrum of gammas  emitted
y the indium foil activated by resonance neutrons. The dif-
erence between the activity Atot induced in the uncovered foil
nd the one induced in the foil shielded by cadmium (Ares),
djusted for the resonance neutron absorption in cadmium,
rovides information about the activity induced by thermal
eutrons: Ather = Atot − Ares = (NCA − NCAin Cd × FCd) × K.
The ﬁnal dependence between the indium foil activity and
he thermal/resonance neutron ﬂuence, when the cadmium
over method is applied, can be expressed as follows:
ther =
AtherWe
tm tp
dmSN0ther(1 − e−tn )(e−tp − 1)
,
res =
AresFCdWe
tm tp
dmSN0C(1 − e−tn )(e−tp − 1)
∫ 100 keV
0.4  eV
dE
E
,
nd
 =
∫ ∞
0.4 eV
(E)
E
dE − the resonance activation integral,
here ˚ther (˚res) is the thermal (resonance) neutron ﬂuence,
ther (Ares) is the measured indium foil detector activity due to
hermal (resonance) neutrons, tp is the time of the measure-
ent of the gamma spectrum from the disintegration of 116Sn*
usually 10 min), tn is the time of exposure to neutron radia-
ion, tm is the time between the end of the neutron exposure
nd the beginning of the measurement of the gamma spec-
rum from the disintegration of 116Sn*, dm is the foil superﬁcial
ensity, ther is the thermal neutron simple capture cross sec-
ion,  is the decay constant (0.012739 min−1 for 116mIn), FCd is
he correction factor for the absorption of resonance neutrons
n the cadmium shield, W is the atomic weight of material
sed as the neutron activation detector (115In), S is the foil area
1.77 cm2 for the used foils) and No is the Avogadro’s number,
 is the neutron energy.
The determined ﬂuence values were normalized to the
herapeutic beam dose Dref in water at the reference
epth. According to the recommendation of the dosimetry
rotocols26,27 the reference depth is 10 cm for all considered
-ray beams, whereas in the case of electrons it depends
n the beam energy (i.e. the reference depth is a depth ofneutron ﬂuence.
maximum dose). Due to the normalization, the presented val-
ues of the neutron ﬂuence are independent of accelerator
efﬁciency. The measurements of the thermal/resonance neu-
tron ﬂuence were performed for the 10 cm × 10 cm radiation
ﬁeld speciﬁed on a therapeutic couch surface. The indium foil
was placed in the center of the radiation ﬁeld on the surface
of a therapeutic couch for SSD (Source Surface Distance) equal
to 100 cm and on walls of the treatment room (Fig. 2) at about
1.0–1.4 m over the ﬂoor surface. The therapeutic beam dose
was referred to the thermal/resonance ﬂuence by a number
of monitor units determining the amount of photon/electron
radiation from a therapeutic beam emitted during the indium
foil activation. The number of monitor units was determined
by the use of an internal dosimetry system of linacs. 6000 mon-
itor units were usually used for each activation (600 monitor
units per minute – a maximal efﬁciency of accelerators, time of
activation: 10 min). Each value of the thermal/resonance neu-
tron ﬂuence presented in this paper comes from averaged data
for three or more  measurements performed for one or two
bunkers. All considered linacs were installed in bunkers with
a similar construction. The bunkers consisted of a treatment
room and a maze. The uncertainty in the determined thermal
and resonance ﬂuence did not exceed 20% when the foils were
exposed to neutrons for 10 min, for the maximal efﬁciency of
accelerators. The time of the foil activity measurement was
10 min. It was enough to determine net count area of the peak
at 1293.54 keV with the accuracy of about 5%.
3.2.  Measurements  of  the  energy  spectra  of  gamma
radiation  from  decays  of  the  induced  radioisotopes
One of the basic methods used to identify radioisotopes orig-
inated from a treatment room is gamma spectroscopy. In the
presented investigation, gamma  spectroscopy was realized
with the use of the ORTEC high-purity germanium detector
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Fig. 3 – The exemplary gamma  energy spectrum from
deexcitation of 116Sn*. The spectrum was measured by the
use of the ORTEC gamma  detection system with the
high-purity germanium detector. During the neutron
activation the foil was placed at the isocentre of the linac
head rotation, thus it was simultaneously not only in the
neutron ﬁeld but also in the gamma/electron ﬁeld. In
connection of this the foil was activated by neutrons in the
simple capture reactions as well by gammas in the
photonuclear reactions or by electrons in electronuclear
reactions. The peaks from the neutron activation are
in Fig. 4 come from the decay of excited state 187Re* being adenoted by n and energy in keV is given.
applied usually for ﬁeld spectrometry (Fig. 1). The detection
system consisted of the above-mentioned detector connected
to a MiniMCA177 multichannel analyzer installed in a PC com-
puter (laptop). The work of the detector was operated by the
M-1-B32 software. Such detection system is relatively small
and can be easily displaced. The energy calibration was per-
formed with the use of a set of commercial calibration sources:
22Na, 54Mn, 60Co, 74Se, 133Ba, 137Cs, and 241Am.  The same
detection system was applied to measure the indium foil activ-
ity in the thermal/resonance neutron measurements. The
details of gamma spectroscopy have been presented in many
publications [see for example28,29]. Analysis of the measured
spectra was based on the knowledge of materials applied in a
construction of the considered linacs. The tables of isotopes
edited by Firestone30 were very useful for this analysis. The
veriﬁcation of the method used was carried out for natural
samples, including uranium series.
4.  Results
An exemplary gamma spectrum from the deexcitation of
116Sn*, measured by the applied detection system is presented
in Fig. 3. Such spectra were the basis of the induced activity
method used for the determination of the indium foil activity
in the presented investigations.
Comparison of the thermal/resonance neutron ﬂuence val-
ues at the isocentre of the linac head rotation is shown in
Table 1. The ﬂuence of thermal neutrons as well as resonance
neutrons connected with the emission of the 20 MV X-rayiotherapy 1 7 ( 2 0 1 2 ) 339–346
beam is about one order of magnitude greater than that for
the 15 MV X-ray beams and about two orders of magnitude
greater than for the considered electron beams, regardless of
the type of an accelerator. In the case of the 15 MV  X-ray beam
emitted by the Elekta-Synergy linac, the thermal neutron ﬂu-
ence is approximately two times less than that for the 15 MV
X-rays from the two remaining considered linacs. However,
the resonance neutron ﬂuence for the 15 MV  X-ray beam from
Elekta-Synergy is at the level of that of the Primus accelerators
and two times less than in the case of 15 MV  X-rays gener-
ated in Clinac-2300. In the case of electron beams emitted by
Primus, the thermal neutron ﬂuence is about two times greater
than the resonance ﬂuence. This tendency is opposite for the
electron beams from Clinac-2300.
The distribution of the thermal/resonance neutron ﬂuence
in treatment rooms with Clinac-2300 and Primus is shown in
Table 2. The thermal and resonance neutron ﬂuence does not
change signiﬁcantly in the treatment rooms. It is the same
order of magnitude in the vicinity of treatment room walls
as at the isocentre of the linac head rotation for both con-
sidered accelerators. Thus, the accelerator accessories can be
activated by neutrons even when they are not used but stored
inside a treatment room during high-energy therapeutic beam
emission.
The measured energy spectra of gammas  emitted by cho-
sen components of an accelerator head are presented in
Figs. 4 and 5. The spectrum of gammas  emitted by the acti-
vated isolated ﬂattening ﬁlter used in Clinac-2300 working in
the 15 MV mode is presented in Fig. 4. The gamma energy spec-
trum for the activated Clinac-2300 electron applicator forming
a 10 cm × 10 cm radiation ﬁeld is shown in Fig. 5.
The peak at 846.77 keV visible in the spectra in Fig. 4 as
well as in Fig. 5 and the peak at 1810.77 keV present in the
spectrum in Fig. 5 come from the decay of excited state 56Fe*
being a consequence of simple capture reactions with 55Mn
– the only natural isotope of manganese (abundance given in
the parenthesis in the reaction notation is equal to 100%):
1
0n + 5525Mn(100%) →  + 5625Mn.
The state of 56Mn is unstable and disintegrates by emission of
ˇ− radiation:
56
25Mn −→
T1/2=2.58 h
ˇ−
+ 5626Fe∗ −→
T1/2<6 ps
56
26Fe(stable) + (846.77 keV, 1810.77 keV).
The maximum range of emitted electrons is 1256 cm in air and
1.6 cm in a biological tissue. The maximum ranges of electrons
from the ˇ− decay in air and in a biological tissue inserted in
this paper were estimated on the base of equivalent values of
exposure constant given by Gostkowska.33 The air density of
0.0013 g/cm3 and the biological tissue density of 1 g/cm3 were
taken for the estimations of the electron ranges.
The peaks at 134.24 keV, 479.59 keV, 551.53 keV, 618.36 keV,
625.51 keV, 685.77 keV and 772.89 keV visible in the spectrumconsequence of the simple capture reactions with 186W:
1
0n + 18674 W(28.6%) →  + 18774 W.
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Table 1 – The thermal (˚ter) and resonance (˚res) neutron ﬂuence values at the isocenter of the linac head rotation,
normalized to a dose Dref in water at the reference depth. The presented values were determined with the use of the
induced activity method. The measurement was performed three or more  times in each measurement point. The
uncertainty in the presented data in the thermal/resonance neutron measurements do not exceed 20%.
Beam Accelerator ˚ter/Dref [cm−2 Gy−1] ˚res/Dref [cm−2 Gy−1]
15 MV X-rays cClinac-2300 3.0 ×105 2.7 ×105
15 MV X-rays aPrimus 3.7 ×105 1.6 ×105
15 MV X-rays aElekta-Synergy 1.4 × 105 1.4 × 105
20 MV X-rays bClinac-2300 1.5 × 106 1.2 × 106
18 MeV electrons bClinac-2300 0.7 × 104 1.4 × 104
18 MeV electrons aPrimus 1.1 × 104 0.6 × 104
21 MeV electrons aPrimus 1.9 × 104 0.8 × 104
22 MeV electrons bClinac-2300 1.0 × 104 2.0 × 104
a Installed in Hospital – Memorial Stanisław Leszczyn´ski in Katowice.
b Installed in Center of Oncology in Gliwice.
c Installed in Greater Poland Cancer Centre in Poznan´.
Table 2 – The thermal (˚ter) and resonance (˚res) neutron ﬂuence values at the chosen locations in the treatment room
(see Fig. 3) during emission of the 15 MV and 20 MV  X-ray beams generated by aPrimus and bClinac-2300, respectively.
Otherwise as in Table 1.
Location 15 MV, Primus 20 MV, Clinac-2300
˚ter/Dref [cm−2 Gy−1] ˚res/Dref [cm−2 Gy−1] ˚ter/Dref [cm−2 Gy−1] ˚res/Dref [cm−2 Gy−1]
A 3.2 × 105 1.0 × 105 1.4 × 106 1.0 × 106
B 2.5 × 105 0.4 × 105 2.1 × 106 1.5 × 106
C 4.1 × 105 0.8 × 105 2.1 × 106 1.5 × 106
D 2.9 × 105 1.1 × 105 1.6 × 106 1.1 × 106
E 2.9 × 105 0.5 × 105 1.6 × 106 1.1 × 106
F 3.9 × 105 1.5 × 105 2.2 × 106 1.5 × 106
G 2.8 × 105 0.4 × 105 1.2 × 106 0.9 × 106
H 2.1 × 105 0.3 × 105 0.1 × 106 0.1 × 106
a Installed in Hospital – Memorial Stanisław Leszczyn´ski in Katowice.
b Installed in Center of Oncology in Gliwice.
Fig. 4 – The energy spectrum of gamma  radiation measured during decays of radioisotopes induced in the ﬂattening ﬁlter of
Clinac-2300 working in the 15 MV mode. The spectrum was measured with the use of an ORTEC detection system with the
high-purity germanium detector (see Fig. 1). The peaks from radioisotopes induced in neutron reactions are denoted by n
and additionally energy in keV was given for each peak. The remaining peaks come mainly from photonuclear reactions.
The ﬂattening ﬁlter was located at the isocentre of the linac head rotation on a treatment couch during emission of the
therapeutic beam. The spectrum was measured immediately after removing the ﬁlter from the beam.
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Fig. 5 – The energy spectrum of gamma  radiation measured during decays of radioisotopes induced in the electron
applicator forming a radiation ﬁeld of 10 cm × 10 cm for Clinac-2300. The electron applicator was stored outside the
therapeutic beam in the corner of a treatment room during emission of therapeutic beams. The spectrum was measured
wise
)immediately after emission of the 15 MV  X-ray beam. Other
The appropriate decay of the unstable state of 187W can be
written as:
187
74 W −→
T1/2=23.72 h
ˇ− + 18775 Re∗ −→
T1/2<1 ms
187
75 Re(stable) + 
× (134.24, 473.59,  551.53,  618.36,  625.51,  685.77,  772.89 in keV
The maximum range of electrons from the ˇ− decay of 187W
is equal to 429 cm in air and 0.6 cm in a biological tissue.
The remaining isotopes of tungsten can change into stable
isotopes or into radioisotopes which do not emit gammas.
The reaction 186W(n,)187W is characterized by the neutron
thermal cross section of 37.9 b,32 the greatest of all natural
tungsten isotopes, and by a relatively large resonance activa-
tion integral of 355 b.24
The high peak at 1778.97 keV visible in the energy spectrum
of gammas  emitted by the electron applicator (Fig. 5) is a result
of the activation of aluminum 27Al with abundance of 100%:
1
0n + 2713Al(100%) →  + 2814Al,
followed by the radioactive decay:
28
13Al −→
T1/2=2.24 m
ˇ− + 2814Si∗ −→
T1/2<1 ps
28
14Si(stable) + (1778.97 keV).
The cross section of the reaction 27Al(n,)28Al is about 0.231 b
at the thermal energy.32 One greater resonance of 4.685 b
appears at 5904 keV.24 The maximum range of electrons from
the ˇ− decay of 28Al is equal to 1265 cm in air and 1.6 cm in a
biological tissue.
The peak at 1039.3 keV present in the spectrum shown in
Fig. 5 is a result of the following simple capture reaction:
1
0n + 6529Cu(30.8%) →  + 6629Cu,followed by the decay of the nucleus of 66Cu:
66
29Cu −→
T1/2=5.1 m
ˇ− + 6630Zn∗ −→
T1/2<1.65 ps
66
30Zn(stable) + (1039.3 keV). as in Fig. 4.
The neutron thermal cross section of 65Cu(n,)66Cu is about
2.17 b.32 The maximum range of electrons from the ˇ− decay
of 66Cu is equal to 1126 cm in air and 1.5 cm in a biological
tissue. Second natural isotope of copper 63Cu with abundance
of 69.17% changes into 64Cu disintegrating by beta decay or
electron capture. In this case, the emission of gammas  (invisi-
ble in the measured spectrum) accompanies only every 200th
decay.
5.  Discussion
The presented values of the thermal ﬂuence connected
with the emission of the X-ray beams are in a good agree-
ment with results obtained by Gudowska and Brahme31
for the various accelerators’ X-ray beams with the nomi-
nal potential nearing the considered ones. Gudowska and
Brahme applied the indium foil as well as the ﬁssion cham-
ber with 235U for the thermal neutron measurements. The
thermal neutron ﬂuences measured during the emission of
a15 MV X-ray beam are very close to that obtained by Liu
at al.34 with the use of activation of the indium foil for
Clinac-2100 working in the 15 MV X-ray mode. Moreover,
the ﬂuences of thermal/resonance neutrons produced dur-
ing the emission of the considered 20 MV  X-rays agree with
those derived by our Monte Carlo calculations presented in
Ref.8
Using the neutron dose equivalent conversion factors given
in Ref.35 effective doses from thermal and resonance neutrons
can be estimated on the basis of the measured neutron ﬂu-
ences. In the case of all considered therapeutic X-ray  beams,
the thermal and resonance neutron effective doses obtained
by patients do not exceed 50 Sv per 1 Gy of therapeutic X-
ray dose. In the case of the considered therapeutic electron
beams, the thermal and resonance neutron effective doses
are about two orders of magnitude less than those for the X-
rays. Thus, the thermal/resonance neutron doses to patients
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3. Ridikas D, Giacri ML, Chadwick MB, et al. Status of the
photonuclear activation ﬁle: reaction cross-section. Fission
fragments and delayed neutrons. Nucl Instrum Methods Phys
Res  A 2006;562:710–3.reports of practical oncology and 
reated by high-energy X-ray/electron beams can be neglected
n considerations of peripheral doses to patients. As shown
n the investigations in Refs.,6,31 the main contribution to
eutron doses to patients comes from fast neutrons. It is
aused by two factors. Firstly, fast neutron ﬂuence is about one
rder of magnitude greater than that for thermal/resonance
eutrons. Secondly, the neutron dose equivalent conversion
actors35 for fast neutrons are about 10 times greater than
or neutrons with thermal and resonance energies. In gen-
ral, in the case of high-energy therapeutic X-rays, the main
ontribution to peripheral doses to patients is given by fast
eutrons and photons from scattering of the primary beam.36
igniﬁcant consequence of the thermal/resonance neutron
xistence is the production of radioisotopes emitting a pen-
trative gamma  radiation and electrons with relatively long
anges for many  materials applied in the accelerator head
onstructions, such as manganese, tungsten, aluminum, and
opper.
The manganese 55Mn  is a component of both considered
ccelerator accessories. In general, it is one of the fundamen-
al components of stainless steel applied in the construction
f various parts of medical accelerators. This isotope is eas-
ly activated by low-energy neutrons, because it has a large
ross section for the neutron capture reaction, i.e. the thermal
eutron capture cross section is 13.2 b32 and the resonance
ctivation integral is 15.7 b,24 with the high resonance peak
ccurring at 337 eV.32
Constructions of heads of the contemporary medical linacs
re characterized by a great amount of tungsten. The con-
idered ﬂattening ﬁlter of Clinac-2300 working in the 15 MV
ode is mainly made of tungsten. There are ﬁve natural
table isotopes of tungsten (abundances in the parenthe-
is): 180W (0.1%), 182W (26.3%), 183W (14.3%), 184W (30.7%) and
86W (28.6%). Three of them (i.e. 180W, 184W and 186W)  can
e changed into radioisotopes in the simple capture reac-
ions. Two of them (i.e. 182W and 183W)  change into stable
uclei when a neutron is captured. The neutron capture reac-
ion with 184W produces 185W – a ˇ− emitter undetected in
amma spectroscopy, whereas the radioisotope of 181W is not
isible in the presented spectra because 180W has too small
bundance.
The large intensity of the peak at 1778.97 keV visible in Fig. 5
s a consequence of a relatively short half-life radioisotope 28Al
nd a large amount of aluminum in the construction of the
lectron applicator. The wires connected to a push sensor on
he bottom of the electron applicator are made of copper. The
mount of this isotope is relatively small in the construction
f the considered electron applicator which results in a low
ntensity peak at 1039.3 keV in spite of a relatively short half-
ife.
In general, radioisotopes identiﬁed in the presented inves-
igations were also observed in other components of medical
ccelerators.15–21 As shown in the presented investigations,
he level of induced radiation and the thermal and reso-
ance neutrons depends mainly on the kind and nominal
otential of therapeutic beams. The type of a linac has
ess inﬂuence on those phenomena. It is caused by the
act that the cross sections of the (,n) and (e,e′n) reactions
epend on the energy of gammas  and electrons [see for
xample21].therapy 1 7 ( 2 0 1 2 ) 339–346 345
6.  Conclusions
1. In general, the thermal as well as resonance neutron ﬂu-
ence depends strongly on the type of the therapeutic beam.
It is greater for X-rays beams than for electrons.
2. In the case of therapeutic X-rays beams, the thermal and
resonance neutron ﬂuence is greater for beams with a
higher nominal potential (the dependence of the neutron
ﬂuence upon a type of a linac is of lower signiﬁcance).
3. The accelerator accessories and other massive objects
should not be stored close to a treatment room during high-
energy therapeutic beam emission, to avoid their activation
caused by the thermal and resonance neutrons. To reduce
the activation of the accelerator components, all replace-
able massive accessories of a linac should be stored outside
the bunker.
4. Neutrons with thermal and resonance energies cause the
simple capture reaction (n,) in which undesirable radioiso-
topes originated. Half-lives of these radioisotopes range
from minutes to hours. Such half-lives are long enough for
components of the accelerator head to accumulate radioac-
tivity. To reduce the radioactivity accumulation, longer
lasting emission of high-energy X-ray beams should be
avoided if possible.
5. The radiation emitted by induced radioisotopes causes
additional doses to staff operating accelerators. The val-
ues of these doses depend mainly on time of emission of
high-energy X-ray beams, intervals between these emis-
sions and time a person spends close to an accelerator
head.
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